Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
2500
¥ million (increase from the previous full-year revenue forecast)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportSecond quarter of the fiscal year ending September 20268 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥24,280 million+87.6%
Operating profit¥526 million+6.0%
Ordinary income¥507 million-1.1%
Net income¥235 million-31.5%
Gross Profit Margin
Rate12.6% (standalone second quarter of the fiscal year ending September 2026)
Year-on-year change (points)Down 0.8 percentage points from 13.4% in the same period of the previous year
Results for the three months of the current quarter
Net Sales
¥13,908 million
EBITDA
¥668 million
Operating profit
¥522 million
Gross Margin
12.6 %
Full-year earnings forecast
Net Sales
¥44,500 million
EBITDA
¥1,185 million
Operating profit
¥680 million
Ordinary income
¥610 million
Profit attributable to owners of the parent
¥230 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Revenue from new construction, expansion and renovation projectsApproximately 35% (progress through the second quarter against the full-year forecast)
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Ordinary profit for the second quarter of the fiscal year ending September 2026
Impact of higher revenue¥0.2 hundred million
Change in gross margin¥-1.8 hundred million
Change in personnel expenses¥0.2 hundred million
Change in other SG&A expenses¥0 hundred million
Non-operating income and expenses¥-0.5 hundred million
ファスキア Group¥4.8 hundred million
Amortization of goodwill and other items¥-1.4 hundred million
Stock acquisition-related expenses¥-1.5 hundred million
Full-year ordinary profit for the fiscal year ending September 2026
Impact of higher revenue¥0.6 hundred million
Change in gross margin¥-1.2 hundred million
Change in personnel expenses¥-0.2 hundred million
Change in other SG&A expenses¥-0.4 hundred million
Non-operating income and expenses¥-1 hundred million
ファスキア Group¥8.6 hundred million
Amortization of goodwill and other items¥-2.7 hundred million
Stock acquisition-related expenses¥-0.5 hundred million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Revenue from new construction, expansion and renovation projects
¥3,900 million
Year on year for new construction, expansion and renovation projectsForecast to decline 52% year on year
Full-year number of new construction, expansion and renovation projects
12 Engagements
Full-year average unit price for new construction, expansion and renovation projects
¥327 10,000
New initiatives
- Plan to absorb the intermediate holding company ファスキア HD in October 2026
- Simplification of the management structure and faster decision-making
Key KPIsA metric the company considers important as a management benchmark.
- EBITDA¥793 millionYear on year against the same period last year+46.5%
- FCF¥-1,940 million
- Net cash¥25 hundred millionYear on year against the same period last yearDown ¥2.2 billion from the end of the previous fiscal year
- Equity ratio21.6 %
- ROE4.1 %
- PBRBelow 1xYear on year against the same period last yearBelow 1x again
Unit price and quantity metricsThese figures show sales broken down by price and volume.
New construction, expansion and renovation projectsRevenue, number of projects and average unit price are disclosed. For the second quarter of the fiscal year ending September 2026, revenue was ¥1.406 billion from 5 projects, with an average unit price of ¥2.81 million. The full-year outlook is revenue of ¥3.930 billion from 12 projects, with an average unit price of ¥3.27 million.
Segment results
Total Medical Solutions
Net Sales
¥12,475 million
Year on year against the same period last year-32.7%
Operating profit
¥304 million
Teleradiology Services
Net Sales
¥412 million
Year on year against the same period last year+0.4%
Operating profit
¥41 million
Minimally Invasive Medical Device Sales
Net Sales
¥10,189 million
Operating profit
¥183 million
Rental
Net Sales
¥317 million
Operating profit
¥37 million
Other
Net Sales
¥885 million
Year on year against the same period last year11.2x year on year
Operating profit
¥18 million
Number of employees
Number of Employees360 people
Average number of temporary employees73 people
Change during the periodIncreased from 155 people in the previous fiscal year to 360
Capital expenditures
¥3,809 million investing cash flow; expenditure for the acquisition of shares in the ファスキア Group
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Second quarter of the fiscal year ending September 2026 |
| Net Sales | ¥24,280 million (YoY +87.6%) |
| Operating profit | ¥526 million (YoY +6.0%) |
| Ordinary income | ¥507 million (YoY -1.1%) |
| Net income | ¥235 million (YoY -31.5%) |
| Gross Profit Margin | Rate 12.6% (standalone second quarter of the fiscal year ending September 2026) / Year-on-year change (points) Down 0.8 percentage points from 13.4% in the same period of the previous year |
| Results for the three months of the current quarter | Net Sales ¥13,908 million / EBITDA ¥668 million / Operating profit ¥522 million / Gross Margin 12.6 % |
| Full-year earnings forecast | Net Sales ¥44,500 million / EBITDA ¥1,185 million / Operating profit ¥680 million / Ordinary income ¥610 million / Profit attributable to owners of the parent ¥230 million |
| Progress against full-year forecast | Revenue from new construction, expansion and renovation projects Approximately 35% (progress through the second quarter against the full-year forecast) |
| Segment results | Total Medical Solutions Net Sales ¥12,475 million / Year on year against the same period last year -32.7 / Operating profit ¥304 million / Teleradiology Services Net Sales ¥412 million / Year on year against the same period last year 0.4 / Operating profit ¥41 million / Minimally Invasive Medical Device Sales Net Sales ¥10,189 million / Operating profit ¥183 million / Rental Net Sales ¥317 million / Operating profit ¥37 million / Other Net Sales ¥885 million / Year on year against the same period last year 11.2x year on year / Operating profit ¥18 million |
| Breakdown of Factors Affecting the Change | Ordinary profit for the second quarter of the fiscal year ending September 2026 Impact of higher revenue ¥0.2 hundred million / Change in gross margin ¥-1.8 hundred million / Change in personnel expenses ¥0.2 hundred million / Change in other SG&A expenses ¥0 hundred million / Non-operating income and expenses ¥-0.5 hundred million / ファスキア Group ¥4.8 hundred million / Amortization of goodwill and other items ¥-1.4 hundred million / Stock acquisition-related expenses ¥-1.5 hundred million / Full-year ordinary profit for the fiscal year ending September 2026 Impact of higher revenue ¥0.6 hundred million / Change in gross margin ¥-1.2 hundred million / Change in personnel expenses ¥-0.2 hundred million / Change in other SG&A expenses ¥-0.4 hundred million / Non-operating income and expenses ¥-1 hundred million / ファスキア Group ¥8.6 hundred million / Amortization of goodwill and other items ¥-2.7 hundred million / Stock acquisition-related expenses ¥-0.5 hundred million |
| Key KPIs | Indicator name EBITDA / Value ¥793 million / Year on year against the same period last year ¥46.5 million, Indicator name FCF / Value ¥-1,940 million / Year on year against the same period last year Not disclosed, Indicator name Net cash / Value ¥25 hundred million / Year on year against the same period last year Down ¥2.2 billion from the end of the previous fiscal year, Indicator name Equity ratio / Value 21.6 % / Year on year against the same period last year Not disclosed, Indicator name ROE / Value 4.1 % / Year on year against the same period last year Not disclosed, Indicator name PBR / Value Below 1x / Year on year against the same period last year Below 1x again |
| Unit price and quantity metrics | New construction, expansion and renovation projects Revenue, number of projects and average unit price are disclosed. For the second quarter of the fiscal year ending September 2026, revenue was ¥1.406 billion from 5 projects, with an average unit price of ¥2.81 million. The full-year outlook is revenue of ¥3.930 billion from 12 projects, with an average unit price of ¥3.27 million. |
| Number of employees | Number of Employees 360 people / Average number of temporary employees 73 people / Change during the period Increased from 155 people in the previous fiscal year to 360 |
| Assumptions Underlying the Business Outlook | Revenue from new construction, expansion and renovation projects ¥3,900 million / Year on year for new construction, expansion and renovation projects Forecast to decline 52% year on year / Full-year number of new construction, expansion and renovation projects 12 Engagements / Full-year average unit price for new construction, expansion and renovation projects ¥327 10,000 |
| Capital expenditures | ¥3,809 million (investing cash flow; expenditure for the acquisition of shares in the ファスキア Group) |
| New initiatives | Plan to absorb the intermediate holding company ファスキア HD in October 2026, Simplification of the management structure and faster decision-making |
Items this document does not state (13)
Operating profit marginSelling, general and administrative expensesSelf-assessment against the planNumber of stores and locationsRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The ファスキア Group, which joined the Group at the beginning of the fiscal year, had a significant impact on the increase in revenue and profit for the six months ended September 2026. The upward revision to the full-year forecast was driven mainly by strong sales of minimally invasive medical devices, with the sales forecast for this business raised by ¥2.9 billion. The decline in net income was attributed to the increased tax expense burden.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.